• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $CHWY

    Chewy Inc.

    Subscribe to $CHWY
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Chewy, Inc., together with its subsidiaries, engages in the pure play e-commerce business in the United States. The company provides pet food and treats, pet supplies and pet medications, and other pet-health products, as well as pet services for dogs, cats, fish, birds, small pets, horses, and reptiles through its chewy.com retail Website, as well as its mobile applications. It offers approximately 70,000 products from 2,500 partner brands. The company was founded in 2010 and is headquartered in Dania Beach, Florida. Chewy, Inc. is a subsidiary of PetSmart, Inc.

    IPO Year: 2019

    Exchange: NYSE

    Website: chewy.com

    Peers

    $PETS
    $WOOF

    Recent Analyst Ratings for Chewy Inc.

    DatePrice TargetRatingAnalyst
    6/9/2025$47.00Outperform → Neutral
    Mizuho
    6/5/2025$43.00Buy → Hold
    Jefferies
    3/24/2025Neutral
    Seaport Research Partners
    1/23/2025Hold → Buy
    Argus
    1/13/2025$34.00 → $47.00In-line → Outperform
    Evercore ISI
    1/6/2025$24.00 → $42.00Neutral → Outperform
    Mizuho
    1/3/2025Peer Perform → Outperform
    Wolfe Research
    12/5/2024Outperform → Neutral
    Exane BNP Paribas
    11/20/2024$24.00 → $40.00Underperform → Buy
    BofA Securities
    11/8/2024$28.00 → $40.00Neutral → Buy
    Citigroup
    See more ratings